References
1. Javanian M, Bayani M, Shokri M, Sadeghi-Haddad-Zavareh M, Babazadeh A, Yeganeh B, et al. Clinical and laboratory findings from patients with COVID-19 pneumonia in Babol North of Iran: a retrospective cohort study. Rom J Intern Med. 2020;58(3):161-7.
2. Javanian M, Bayani M, Shokri M, Sadeghi-Haddad-Zavareh M, Babazadeh A, Ghadimi R, et al. Risk factors for mortality of 557 adult patients with COVID 19 in Babol, Northern Iran: a retrospective cohort study. Bratisl Lek Listy. 2021;122(1):34-8.
3. Javanian M, Masrour-roudsari J, Bayani M, Ebrahimpour S. Coronavirus disease 2019 (COVID-19): What we need to know. Caspian Journal of Internal Medicine. 2020;11(2):235-6.
4. Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020;146(1):110-8.
5. Al-Quteimat OM, Amer AM. The Impact of the COVID-19 Pandemic on Cancer Patients. Am J Clin Oncol. 2020;43(6):452-5.
6. Tian J, Yuan X, Xiao J, Zhong Q, Yang C, Liu B, et al. Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study. Lancet Oncol. 2020;21(7):893-903.
7. Karacin C, Bilgetekin I, B Basal F, Oksuzoglu OB. How does COVID-19 fear and anxiety affect chemotherapy adherence in patients with cancer. Future Oncology. 2020;16(29):2283-93.
8. Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335-7.
9. Zhang L, Zhu F, Xie L, Wang C, Wang J, Chen R, et al. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Annals of oncology. 2020;31(7):894-901.
10. Derosa L, Melenotte C, Griscelli F, Gachot B, Marabelle A, Kroemer G, et al. The immuno-oncological challenge of COVID-19. Nature Cancer. 2020;1(10):946-64.
11. Afshar ZM, Ebrahimpour S, Javanian M, Koppolu V, Vasigala VKR, Hasanpour AH, et al. Coronavirus disease 2019 (COVID-19), MERS and SARS: Similarity and difference. Journal of Acute Disease. 2020;9(5):194.
12. Russell B, Moss C, George G, Santaolalla A, Cope A, Papa S, et al. Associations between immune-suppressive and stimulating drugs and novel COVID-19—a systematic review of current evidence. ecancermedicalscience. 2020;14.
13. Wang L, Sun Y, Yuan Y, Mei Q, Yuan X. Clinical challenges in cancer patients with COVID-19: Aging, immunosuppression, and comorbidities. Aging (Albany NY). 2020;12(23):24462-74.
14. Luo J, Rizvi H, Preeshagul IR, Egger JV, Hoyos D, Bandlamudi C, et al. COVID-19 in patients with lung cancer. Ann Oncol. 2020;31(10):1386-96.
15. Yin J, Kasper B, Petersen F, Yu X. Association of Cigarette Smoking, COPD, and Lung Cancer With Expression of SARS-CoV-2 Entry Genes in Human Airway Epithelial Cells. Front Med (Lausanne). 2020;7:619453.
16. Mehta V, Goel S, Kabarriti R, Cole D, Goldfinger M, Acuna-Villaorduna A, et al. Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System. Cancer Discov. 2020;10(7):935-41.
17. Afshar ZM, Dayani M, Naderi M, Ghanbarveisi F, Shiri S, Rajati F. Fatality rate of COVID-19 in patients with malignancies: a sytematic review and meta-analysis. J Infect. 2020;81(2):e114-e6.
18. Fox TA, Troy-Barnes E, Kirkwood AA, Chan WY, Day JW, Chavda SJ, et al. Clinical outcomes and risk factors for severe COVID-19 in patients with haematological disorders receiving chemo- or immunotherapy. Br J Haematol. 2020;191(2):194-206.
19. Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033-4.
20. Robilotti EV, Babady NE, Mead PA, Rolling T, Perez-Johnston R, Bernardes M, et al. Determinants of COVID-19 disease severity in patients with cancer. Nat Med. 2020;26(8):1218-23.
21. Yeoh CB, Lee KJ, Rieth EF, Mapes R, Tchoudovskaia AV, Fischer GW, et al. COVID-19 in the Cancer Patient. Anesth Analg. 2020;131(1):16-23.
22. Lièvre A, Turpin A, Ray-Coquard I, Le Malicot K, Thariat J, Ahle G, et al. Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19). European Journal of Cancer. 2020;141:62-81.
23. Rogado J, Pangua C, Serrano-Montero G, Obispo B, Marino AM, Perez-Perez M, et al. Covid-19 and lung cancer: A greater fatality rate? Lung Cancer. 2020;146:19-22.
24. Dinmohamed AG, Visser O, Verhoeven RHA, Louwman MWJ, van Nederveen FH, Willems SM, et al. Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands. Lancet Oncol. 2020;21(6):750-1.
25. Kutikov A, Weinberg DS, Edelman MJ, Horwitz EM, Uzzo RG, Fisher RI. A war on two fronts: cancer care in the time of COVID-19. American College of Physicians; 2020.
26. Mohindra P, Buckey CR, Chen S, Sio TT, Rong Y. Radiation therapy considerations during the COVID-19 Pandemic: Literature review and expert opinions. J Appl Clin Med Phys. 2020;21(5):6-12.
27. Larson C, Oronsky B, Goyal S, Ray C, Hedjran F, Hammond TC, et al. COVID-19 and cancer: A guide with suggested COVID-19 rule-out criteria to support clinical decision-making. Biochim Biophys Acta Rev Cancer. 2020;1874(2):188412.
28. Arpino G, De Angelis C, De Placido P, Pietroluongo E, Formisano L, Bianco R, et al. Optimising triage procedures for patients with cancer needing active anticancer treatment in the COVID-19 era. ESMO Open. 2020;5(5):e000885.
29. Weisel KC, Morgner-Miehlke A, Petersen C, Fiedler W, Block A, Schafhausen P, et al. Implications of SARS-CoV-2 Infection and COVID-19 Crisis on Clinical Cancer Care: Report of the University Cancer Center Hamburg. Oncol Res Treat. 2020;43(6):307-13.
30. Jonker PKC, van der Plas WY, Steinkamp PJ, Poelstra R, Emous M, van der Meij W, et al. Perioperative SARS-CoV-2 infections increase mortality, pulmonary complications, and thromboembolic events: A Dutch, multicenter, matched-cohort clinical study. Surgery. 2021;169(2):264-74.
31. Aghili M, Ghalehtaki R, Mousavi Darzikolaee N, Jafari F, Moshtaghian M. Radiotherapy and COVID-19: Practical recommendations from iran. Radiother Oncol. 2020;149:70-1.
32. Back D, Marzolini C, Hodge C, Marra F, Boyle A, Gibbons S, et al. COVID-19 treatment in patients with comorbidities: Awareness of drug-drug interactions. Br J Clin Pharmacol. 2021;87(1):212-3.
33. Behzad S, Aghaghazvini L, Radmard AR, Gholamrezanezhad A. Extrapulmonary manifestations of COVID-19: Radiologic and clinical overview. Clin Imaging. 2020;66:35-41.
34. Doroudinia A, Hosseinzadeh E, Asli IN, Karam MB, Mehrian P. Diagnostic errors of coronavirus infection: Role of fluorodeoxyglucose positron emission tomography/computed tomography scan. Biomedical and Biotechnology Research Journal (BBRJ). 2020;4(4):337.
35. Bartlett DL, Howe JR, Chang G, Crago A, Hogg M, Karakousis G, et al. Management of Cancer Surgery Cases During the COVID-19 Pandemic: Considerations. Ann Surg Oncol. 2020;27(6):1717-20.
36. Tzeng CD, Teshome M, Katz MHG, Weinberg JS, Lai SY, Antonoff MB, et al. Cancer Surgery Scheduling During and After the COVID-19 First Wave: The MD Anderson Cancer Center Experience. Ann Surg. 2020;272(2):e106-e11.
37. Menetrier-Caux C, Ray-Coquard I, Blay JY, Caux C. Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines? J Immunother Cancer. 2019;7(1):85.
38. Silvestris N, Munafo A, Brunetti O, Burgaletto C, Scucces L, Bernardini R. On the Management of Drug Interactions in the Course of Concomitant Treatments for COVID-19 and Antineoplastic Agents. Front Oncol. 2020;10:1340.
39. Palma Fedele VS, Fancellu A, Marino A, Calvani N, Cinieri S. De-escalating cancer treatments during COVID 19 pandemic: Is metronomic chemotherapy a reasonable option? Critical Reviews in Oncology/Hematology. 2021;157:103148.
40. Iorio GC, Ricardi U, Dal Pra A. Radiation-Induced Lymphopenia Beyond the COVID-19 Pandemic. Front Oncol. 2020;10:617302.
41. Wu S, Zheng D, Liu Y, Hu D, Wei W, Han G. Radiation Therapy Care During a Major Outbreak of COVID-19 in Wuhan. Adv Radiat Oncol. 2020;5(4):531-3.
42. Lingos TI, Recht A, Vicini F, Abner A, Silver B, Harris JR. Radiation pneumonitis in breast cancer patients treated with conservative surgery and radiation therapy. Int J Radiat Oncol Biol Phys. 1991;21(2):355-60.
43. Lancia A, Bonzano E, Bottero M, Camici M, Catellani F, Ingrosso G. Radiotherapy in the era of COVID-19. Taylor & Francis; 2020.
44. Gonnelli A, Montrone S, Cocuzza P, Ursino S, Manfredi B, Mattioni R, et al. Radiotherapy in the COVID-19 Pandemic Era. In Vivo. 2020;34(6):3731-4.
45. Yahalom J, Dabaja BS, Ricardi U, Ng A, Mikhaeel NG, Vogelius IR, et al. ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemic. Blood. 2020;135(21):1829-32.
46. Anderson N, Thompson K, Andrews J, Chesson B, Cray A, Phillips D, et al. Planning for a pandemic: Mitigating risk to radiation therapy service delivery in the COVID-19 era. J Med Radiat Sci. 2020;67(3):243-8.
47. Weber JS, Yang JC, Atkins MB, Disis ML. Toxicities of Immunotherapy for the Practitioner. J Clin Oncol. 2015;33(18):2092-9.
48. Gavillet M, Carr Klappert J, Spertini O, Blum S. Acute leukemia in the time of COVID-19. Leuk Res. 2020;92:106353.
49. Ogonek J, Kralj Juric M, Ghimire S, Varanasi PR, Holler E, Greinix H, et al. Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation. Front Immunol. 2016;7:507.
50. Burki TK. Cancer care in the time of COVID-19. Lancet Oncol. 2020;21(5):628.
51. Raymond E, Thieblemont C, Alran S, Faivre S. Impact of the COVID-19 Outbreak on the Management of Patients with Cancer. Target Oncol. 2020;15(3):249-59.
52. Cortiula F, Pettke A, Bartoletti M, Puglisi F, Helleday T. Managing COVID-19 in the oncology clinic and avoiding the distraction effect. Ann Oncol. 2020;31(5):553-5.
53. Bland KA, Bigaran A, Campbell KL, Trevaskis M, Zopf EM. Exercising in Isolation? The Role of Telehealth in Exercise Oncology During the COVID-19 Pandemic and Beyond. Phys Ther. 2020;100(10):1713-6.
54. Lin DD, Meghal T, Murthy P, Mo L, D’Silva A, Huang Y, et al. Chemotherapy treatment modifications during the COVID-19 outbreak at a Community Cancer Center in New York City. JCO global oncology. 2020;6:1298-305.
55. Alom S, Chiu CM, Jha A, Lai SHD, Yau THL, Harky A. The Effects of COVID-19 on Cancer Care Provision: A Systematic Review. Cancer Control. 2021;28:1073274821997425.
56. Chan WL, Ho P, Yuen KK. Impacts of social distancing on cancer care during COVID-19 pandemic: Hong Kong experience. Palliat Support Care. 2020:1-8.
57. Aznab M, Eskandari Roozbahani N, Moazen H. Value of influenza vaccines in cancer patients during the coronavirus (COVID-19) pandemic: a cross-sectional study. Support Care Cancer. 2021:1-7.
58. Silvestris N, Brunetti O, Bernardini R, Cinieri S. COVID vaccination in cancer patients: what vaccination priority strategies should there be? Frontiers in Oncology. 2021;11:168.
59. Kotecha RS. Challenges posed by COVID-19 to children with cancer. Lancet Oncol. 2020;21(5):e235.
60. Cheung AT, Li WHC, Ho LLK, Chan GCF, Chung JOK. Health support to pediatric cancer survivors and their families during the COVID‐19 pandemic. Pediatric Blood & Cancer. 2020.
61. Stebbing J, Phelan A, Griffin I, Tucker C, Oechsle O, Smith D, et al. COVID-19: combining antiviral and anti-inflammatory treatments. Lancet Infect Dis. 2020;20(4):400-2.
62. Jin Z, Zhao Y, Sun Y, Zhang B, Wang H, Wu Y, et al. Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur. Nat Struct Mol Biol. 2020;27(6):529-32.
63. Favalli EG, Biggioggero M, Maioli G, Caporali R. Baricitinib for COVID-19: a suitable treatment? Lancet Infect Dis. 2020;20(9):1012-3.
64. Mehta P, Ciurtin C, Scully M, Levi M, Chambers RC. JAK inhibitors in COVID-19: the need for vigilance regarding increased inherent thrombotic risk. European Respiratory Journal. 2020;56(3).
65. Guo Y, Xu F, Lu T, Duan Z, Zhang Z. Interleukin-6 signaling pathway in targeted therapy for cancer. Cancer Treat Rev. 2012;38(7):904-10.
66. Saha A, Sharma AR, Bhattacharya M, Sharma G, Lee SS, Chakraborty C. Tocilizumab: A Therapeutic Option for the Treatment of Cytokine Storm Syndrome in COVID-19. Arch Med Res. 2020;51(6):595-7.
67. Stadler R, Bratzke B, Orfanos C. Therapeutic use of alpha interferon in metastasizing malignant melanoma, disseminated Kaposi sarcoma and severe Behçet disease. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete. 1987;38(8):453-60.
68. Welsh RM, Bahl K, Marshall HD, Urban SL. Type 1 interferons and antiviral CD8 T-cell responses. PLoS Pathog. 2012;8(1):e1002352.
69. Cortese I, Muranski P, Enose-Akahata Y, Ha SK, Smith B, Monaco M, et al. Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy. N Engl J Med. 2019;380(17):1597-605.
70. Gatto L, Franceschi E, Nunno VD, Brandes AA. Potential protective and therapeutic role of immune checkpoint inhibitors against viral infections and COVID-19. Future Medicine; 2020.
71. Tailor IK, Alshehry NF, Zaidi SZ, Marei MA, Motabi IH, Alfayez M, et al. Outcome of myeloma patients with COVID-19 on active lenalidomide-based therapy: Does lenalidomide protect from severe COVID-19? Hematology/Oncology and Stem Cell Therapy. 2020.
72. Agresti N, Lalezari JP, Amodeo PP, Mody K, Mosher SF, Seethamraju H, et al. Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab. J Transl Autoimmun. 2021;4:100083.
73. Ribas A, Sengupta R, Locke T, Zaidi SK, Campbell KM, Carethers JM, et al. Priority COVID-19 vaccination for patients with cancer while vaccine supply is limited. Cancer discovery. 2021;11(2):233-6.
74. Ting FI, Uy CD, Bebero KG, Sacdalan DB, Dennis Sacdalan M, Abarquez HS. COVID-19 Vaccine and Patients with Cancer. cancer. 2021;1:6.
75. Hwang JK, Zhang T, Wang AZ, Li Z. COVID-19 vaccines for patients with cancer: benefits likely outweigh risks. Journal of hematology & oncology. 2021;14(1):1-11.
76. Brodziak A, Sigorski D, Osmola M, Wilk M, Gawlik-Urban A, Kiszka J, et al. Attitudes of Patients with Cancer towards Vaccinations-Results of Online Survey with Special Focus on the Vaccination against COVID-19. Vaccines (Basel). 2021;9(5):411.
77. Khorrami Z, Nili S, Sharifi H, Eybpoosh S, Shokoohi M. Association of cigarette smoking, obesity, and underlying medical conditions with COVID-19 hospitalization and mortality in Iran: A nationwide retrospective ecological study. Med J Islam Repub Iran. 2020;34:133-.
78. Carson KV, Usmani ZA, Robertson TA, Mysore S, Brinn MP. Smoking cessation interventions for lung cancer patients. Lung Cancer Management. 2013;2(1):61-74.
79. Koo HY, Lee K, Park SM, Chang J, Kim K, Choi S, et al. Prevalence and Predictors of Sustained Smoking after a Cancer Diagnosis in Korean Men. Cancer Res Treat. 2020;52(1):139-48.
80. Gritz ER, Talluri R, Fokom Domgue J, Tami-Maury I, Shete S. Smoking Behaviors in Survivors of Smoking-Related and Non–Smoking-Related Cancers. JAMA Network Open. 2020;3(7):e209072-e.
81. Brake SJ, Barnsley K, Lu W, McAlinden KD, Eapen MS, Sohal SS. Smoking Upregulates Angiotensin-Converting Enzyme-2 Receptor: A Potential Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19). J Clin Med. 2020;9(3):841.
82. Reddy RK, Charles WN, Sklavounos A, Dutt A, Seed PT, Khajuria A. The effect of smoking on COVID-19 severity: A systematic review and meta-analysis. Journal of Medical Virology. 2021;93(2):1045-56.
83. Simons D, Shahab L, Brown J, Perski O. The association of smoking status with SARS-CoV-2 infection, hospitalization and mortality from COVID-19: a living rapid evidence review with Bayesian meta-analyses (version 7). Addiction. 2021;116(6):1319-68.
84. Cho ER, Jha P, Slutsky AS. Smoking and the risk of COVID-19 infection in the UK Biobank Prospective Study. medRxiv. 2020:2020.05.05.20092445.
85. Farsalinos K, Barbouni A, Niaura R. Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option? Internal and Emergency Medicine. 2020;15(5):845-52.
86. Busetto L, Bettini S, Fabris R, Serra R, Dal Pra C, Maffei P, et al. Obesity and COVID-19: An Italian Snapshot. Obesity. 2020;28(9):1600-5.
87. Kalligeros M, Shehadeh F, Mylona EK, Benitez G, Beckwith CG, Chan PA, et al. Association of Obesity with Disease Severity Among Patients with Coronavirus Disease 2019. Obesity. 2020;28(7):1200-4.
88. Yang J, Hu J, Zhu C. Obesity aggravates COVID-19: A systematic review and meta-analysis. Journal of Medical Virology. 2021;93(1):257-61.
89. Simonnet A, Chetboun M, Poissy J, Raverdy V, Noulette J, Duhamel A, et al. High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Requiring Invasive Mechanical Ventilation. Obesity. 2020;28(7):1195-9.
90. van Kruijsdijk RCM, van der Wall E, Visseren FLJ. Obesity and Cancer: The Role of Dysfunctional Adipose Tissue. Cancer Epidemiology Biomarkers & Prevention. 2009;18(10):2569-78.